

Hemodialysis treatment outcomes and patient-reported outcomes in a single-center pilot study
https://doi.org/10.36485/1561-6274-2025-29-1-75-87
EDN: BPMUEL
Abstract
BACKGROUND. Achieving the best outcomes of dialysis treatment is hindered by limited monitoring of important parameters and lack of consensus on minimum and optimal standards of safety, quality of dialysis, and its organization, which prevents comparative analysis. After running out the possibilities to improve dialysis outcomes by increasing diffusion and convection transfer, the researchers turned to evaluating patient-reported outcomes and ways to improve them. THE AIM. To present the results of a pilot study of symptoms severity and prevalence, as well as their relationship to the treatment characteristics. PATIENTS AND METHODS. In a one-center cohort study, we included 137 patients aged 55±15 years, 41 % women. Symptoms were assessed by the Dialysis Symptom Index, 30 symptoms with a score of 1-5 ("not bothering at all" - "very bothering"). The dialysis monitoring program included monthly/quarterly routine indicators of uremic syndromes correction, assessment of bioimpedance, degree of protein-energy wasting, and sarcopenia. RESULTS. The average symptom score was 50±15 (Me; Q1-Q3: 50, 37-60, from 30 (no symptoms) to 109), a direct relationship was found between the severity and prevalence of symptoms. The overall score in the multiple regression analysis was directly related to the severity of protein-energy wasting (+3.8 points/degree, (95 %CI 0.5-7; p=0.022), phosphate levels (+0.17 points/0.1 mmol/l; (0.03–0.30; p=0.017), and inversely – with hemoglobin level (-0.26 points / 1 g/l; -0.49-(-0.03); p= 0.024), albumin (-0.18 points/1 g/ l; -0.36-(-0.001); p = 0.047), grip power (-0.17 points/1 kg; -0.49-(-0.03); p= 0.024). CONCLUSION. Dialysis patients have a severe symptomatic burden. The symptom clusters demonstrate numerous links with the treatment parameters, which opens up the possibility for targeted interventions in order to achieve better outcomes.
About the Authors
Karim Rizk Mahmoud Al-BarbariRussian Federation
Al-Barbari Karim Rizk Mahmoud, nephrologist of dialysis department,
56, Liteiny pr.,Saint Petersburg, 191104.
Konstantin A. Vishnevskii
Russian Federation
Vishnevskii Konstantin Alexandrovich, Candidate of Medical Sciences, Associate Professor of the Department of Internal Medicine, Nephrology, General and Clinical Pharmacology with Pharmacy course; Head of Dialysis Department,
41, Kirochnaya str., St. Petersburg, 191015;
56, Liteiny pr., St. Petersburg, 191104.
Pavel A. Karpov
Russian Federation
Karpov Pavel Alekseevich, nephrologist of dialysis department,
56, Liteiny pr., Saint Petersburg, 191104.
Julia Yu. Zhernova
Russian Federation
Zhernova Julia Yurievna, nephrologist of dialysis department,
56, Liteiny pr., Saint Petersburg, 191104.
Alexander Yu. Zemchenkov
Russian Federation
Zemchenkov Alexander Yuryevich – Candidate of Medical Sciences, Associate Professor, nephrologist of dialysis department,
56, Liteiny pr.,Saint Petersburg, 191104.
Alexander Sh. Rumyantsev
Russian Federation
Rumyantsev Alexander Shalikovich, MD, PhD, DMedSci, Professor of the Department of Faculty Therapy; Department of Propaedeutics of Internal Diseases with the Clinic named after Academician M.D. Tushinsky,
8a, 21st line V.O., , St. Petersburg, 199106;
6-8, L. Tolstoy str., St. Petersburg, 197022.
References
1. Sola L, Levin NW, Johnson DW et al. Development of a framework for minimum and optimal safety and quality standards for hemodialysis and peritoneal dialysis. Kidney Int Suppl (2011) 2020;10(1):e55–e62. https://doi.org/10.1016/j.kisu.2019.11.009
2. Tong A, Manns B, Wang AYM et al. SONG Implementation Workshop Investigators. Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop. Kidney Int 2018;94(6):1053–1068. https://doi.org/10.1016/j.kint.2018.08.018
3. Flythe JE, Hilliard T, Castillo G et al. Symptom Prioritization among Adults Receiving In-Center Hemodialysis: A Mixed Methods Study. Clin J Am Soc Nephrol 2018;13(5):735–745. https://doi.org/10.2215/CJN.10850917
4. Huang LT, Zheng XY, Zhang ZH et al. Translation, cultural adaptation, and validation of the Chinese standardized outcomes in nephrology-hemodialysis fatigue (C-SONG-HD fatigue) scale: a study of Chinese patients undergoing hemodialysis. Qual Life Res 2024;33(3):745–752. https://doi.org/10.1007/s11136-02303561-4.
5. Fletcher BR, Damery S, Aiyegbusi OL et al. Symptom burden and health-related quality of life in chronic kidney disease: A global systematic review and meta-analysis. PLoS Med 2022;19(4):e1003954. https://doi.org/10.1371/journal.pmed
6. Knoop V, Mathot E, Louter F et al. Measurement properties of instruments to measure the fatigue domain of vitality capacity in community-dwelling older people: an umbrella review of systematic reviews and meta-analysis. Age Ageing 2023;52(Suppl 4):iv26–iv43. https://doi.org/10.1093/ageing/afad140
7. Gutiérrez-Peredo GB, Silva Martins MT, da Silva FA et al. Self-Reported Fatigue by the Chalder Fatigue Questionnaire and Mortality in Brazilian Hemodialysis Patients: The PROHEMO. Nephron 2024;148(5):292–299. https://doi.org/10.1159/000533472
8. Dano S, Hussain J, Edwards N et al. Assessing Fatigue in Patients Receiving Kidney Replacement Therapy Using PROMIS Computer Adaptive Testing. Am J Kidney Dis 2023;82(1):33–42. e1. https://doi.org/10.1053/j.ajkd.2022.12.018
9. Ju A, Teixeira-Pinto A, Tong A et al. Validation of a Core Patient-Reported Outcome Measure for Fatigue in Patients Receiving Hemodialysis: The SONG-HD Fatigue Instrument. Clin J Am Soc Nephrol 2020;15(11):1614–1621. doi: 10.2215/CJN.05880420
10. Natale P, Ju A, Strippoli GF et al. Interventions for fatigue in people with kidney failure requiring dialysis. Cochrane Database Syst Rev 2023;8(8):CD013074. https://doi.org/10.1002/14651858.CD013074.pub2
11. Lu X, Yang J, Bai D et al. Effect of Exercise on Fatigue in Patients Receiving Maintenance Hemodialysis Treatment: A Systematic Review and Network Meta-analysis. Am J Phys Med Rehabil 2024;103(4):293–301. https://doi.org/10.1097/PHM.0000000000002348
12. Takahashi A. The pathophysiology of leg cramping during dialysis and the use of carnitine in its treatment. Physiol Rep 2021;9(21):e15114. https://doi.org/10.14814/phy2.15114
13. Davison SN, Rathwell S, Ghosh S et al. The Prevalence and Severity of Chronic Pain in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Can J Kidney Health Dis 2021;8:2054358121993995. https://doi.org/10.1177/2054358121993995
14. Khramilin VN, Davydov OS. Painful diabetic polyneuropathy: evidence-based diagnosis and treatment. Russian journal of pain 2021;19(4):44–59. (In Russ.) https://doi.org/10.17116/pain20211904144.
15. Nikitina TP, Parshina EV, Tolkach AD et al. Approbation of a series of questionnaires for comprehensive assessment of pruritus and its impact on quality of life in patients with chronic kidney disease receiving hemodialysis. Nephrology and Dialysis 2023;25(4):527–540. (In Russ.) https://doi.org/10.28996/26189801-2023-4-527-540
16. Safarpour Y, Vaziri ND, Jabbari B. Restless Legs Syndrome in Chronic Kidney Disease – a Systematic Review. Tremor Other Hyperkinet Mov (N Y) 2023;13:10. https://doi.org/10.5334/tohm.752
17. Zhou XH, Liu Y, Zhang XR et al. Global prevalence of restless legs syndrome among hemodialysis patients: A systematic review and meta-analysis. Brain Behav 2024;14(1):e3378. https://doi.org/10.1002/brb3.3378
18. La Manna G, Pizza F, Persici E et al. Restless legs syndrome enhances cardiovascular risk and mortality in patients with endstage kidney disease undergoing long-term haemodialysis treatment. Nephrol Dial Transplant 2011;26(6):1976–1983. https://doi.org/10.1093/ndt/gfq681
19. Corbett KS, Chang DH, Riehl-Tonn VJ et al. Sexual Activity, Function, and Satisfaction in Reproductive-Aged Females Living with Chronic Kidney Disease. Healthcare (Basel) 2024;12(17):1728. https://doi.org/10.3390/healthcare12171728
20. Pizzol D, Xiao T, Yang L et al. Prevalence of erectile dysfunction in patients with chronic kidney disease: a systematic review and meta-analysis. Int J Impot Res 2021;33(5):508–515. https://doi.org/10.1038/s41443-020-0295-8
21. Tan LH, Chen PS, Chiang HY et al. Insomnia and Poor Sleep in CKD: A Systematic Review and Meta-analysis. Kidney Med 2022;4(5):100458. https://doi.org/10.1016/j.xkme.2022.100458
22. Yang H, Qi L, Pei D. Effect of psychosocial interventions for depression in adults with chronic kidney disease: a systematic review and meta-analysis. BMC Nephrol.2024;25(1):17. https://doi.org/10.1186/s12882-023-03447-0
23. Palmer SC, Vecchio M, Craig JC et al. Association between depression and death in people with CKD: a meta-analysis of cohort studies. Am J Kidney Dis 2013;62(3):493–505. https://doi.org/10.1053/j.ajkd.2013.02.369
24. Shorey S, Ng ED, Wong CHJ. Global prevalence of depression and elevated depressive symptoms among adolescents: A systematic review and meta-analysis. Br J Clin Psychol 2022;61(2):287–305. https://doi.org/10.1111/bjc.12333
25. Gebrie MH, Ford J. Depressive symptoms and dietary non-adherence among end stage renal disease patients undergoing hemodialysis therapy: systematic review. BMC Nephrol 2019;20(1):429. https://doi.org/10.1186/s12882-019
26. Li Y, Zhu B, Shen J, Miao L. Depression in maintenance hemodialysis patients: What do we need to know? Heliyon 2023;9(9):e19383. https://doi.org/10.1016/j.heliyon.2023.e19383
27. Zhang S, Xu Y, Xia Y. The efficacy and safety of sertraline in maintenance hemodialysis patients with depression: A randomized controlled study. J Affect Disord 2024;352:60–66. https://doi.org/10.1016/j.jad.2024.02.002
28. Huang CW, Wee PH, Low LL et al. Prevalence and risk factors for elevated anxiety symptoms and anxiety disorders in chronic kidney disease: A systematic review and meta-analysis. Gen Hosp Psychiatry 2021;69:27–40. https://doi.org/10.1016/j.genhosppsych.2020.12.003
29. González-Flores CJ, Garcia-Garcia G, Lerma C et al. Effect of Cognitive Behavioral Intervention Combined with the Resilience Model to Decrease Depression and Anxiety Symptoms and Increase the Quality of Life in ESRD Patients Treated with Hemodialysis. Int J Environ Res Public Health 2023;20(11):5981. https://doi.org/10.3390/ijerph20115981
30. Mehrotra R, Davison SN, Farrington K et al. Conference Participants. Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2023;104(3):441–454. https://doi.org/10.1016/j.kint.2023.05.019
31. Weisbord SD, Fried LF, Arnold RM et al. Development of a symptom assessment instrument for chronic hemodialysis patients: the Dialysis Symptom Index. J Pain Symptom Manage 2004;27(3):226–240. https://doi.org/10.1016/j.jpainsymman.2003.07.004
32. Strokov GA, Gurevich KYa, Ilyin AP et al. Treatment of patients with chronic kidney disease stage 5 (CKD 5) by hemodialysis and hemodiafiltration. Clinical guidelines. Nephrology 2017; 21(3):92–111. (in Russ).] https://doi.org/10.24884/1561-62742017-3-92-111
33. Rumyantsev ASh, Vishnevsky KA. Screening of protein-energy wasting in patients of St Petersburg dialysis centers. Nephrology (Saint-Petersburg) 2015;19(6):34–38. (In Russ.)
34. Lavrishcheva IV, Rumyantsev ASh, Zakharov MV et al. Sarcopenia is an actual problem in chronic kidney disease of the 5D stage. Nephrology (Saint-Petersburg) 2020;24(1):60–66. (In Russ.). https://doi.org/10.36485/1561-6274-2020-24-1-60-66
35. Liu J, Purtell L, Bonner A. Kidney Supportive Care for Working-Age Adults with Chronic Kidney Disease: A Profile of Characteristics and Symptom Burden. Nephron 2024;148(1):34–42. https://doi.org/10.1159/000531872
36. Karaaslan T, Pembegul I. Relationship between symptom burden and dialysis adequacy in patients with chronic kidney disease undergoing hemodialysis. North Clin Istanb 2023;10(4):435–443. https://doi.org/10.14744/nci.2023.01799
37. Duan DF, Liu M, Ma DY et al. Exploring Symptom Clusters in Chinese Patients with Diabetic Kidney Disease: A Network Analysis. Int J Gen Med 2024;17:871–884. https://doi.org/10.2147/IJGM.S447921
Review
For citations:
Al-Barbari K., Vishnevskii K.A., Karpov P.A., Zhernova J.Yu., Zemchenkov A.Yu., Rumyantsev A.Sh. Hemodialysis treatment outcomes and patient-reported outcomes in a single-center pilot study. Nephrology (Saint-Petersburg). 2025;29(1):75-87. (In Russ.) https://doi.org/10.36485/1561-6274-2025-29-1-75-87. EDN: BPMUEL